The tributes were warm for Werner Lanthaler when he stepped down as CEO as Evotec SE at the beginning of the year but a chill has descended at the German biotech amid concerns about alleged misconduct by the industry veteran in his buying and selling of company shares.
Lanthaler cited personal reasons for resigning on 3 January "after an extremely challenging, and also physically and overall, very exhausting...